This paper is marked retracted in the scholarly record (OpenAlex). Interpret its findings with caution.
[Retracted] MicroRNA‑17‑5p contributes to osteoarthritis progression by binding p62/SQSTM1
Huihui Li, Daoyi Miao, Qi Zhu, Jianghua Huang, Guangxian Lu, Weiguo Xu
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsOsteoarthritis Treatment and Mechanisms · Cancer-related molecular mechanisms research · Cytokine Signaling Pathways and Interactions
Exp Ther Med 15:1789–1794, 2018; DOI: 10.3892/etm.2017.5622
Following the publication of this paper, it was drawn to the Editor’s attention by a concerned reader that the western blotting data shown in Fig. 3C and D on p. 1792, in addition to the style of presentation of the diagram showing the binding site between miR-17-5p and p62 in Fig. 3A, were strikingly similar to the contents of Fig. 2 in a different article written by different authors at different research institutes, which had already been submitted for publication one month in advance of the above paper to the journal Die Pharmazie.
Owing to the fact that the above-mentioned data had already been submitted for publication prior to its submission to Experimental and Therapeutic Medicine, the Editor has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a reply. The Editor apologizes to the readership for any inconvenience caused.